ROLE OF THE FUSOGENIC PEPTIDE SEQUENCE IN SYNCYTIUM INDUCTION AND INFECTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2

被引:35
作者
STEFFY, KR
KRAUS, G
LOONEY, DJ
WONGSTAAL, F
机构
[1] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093
[3] VET ADM MED CTR,SAN DIEGO,CA 92161
关键词
D O I
10.1128/JVI.66.7.4532-4535.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Syncytium induction is a characteristic feature of infection by human immunodeficiency virus (HIV in vitro. The hydrophobic amino terminus of the transmembrane glycoprotein of HIV type 1 is an essential determinant of virus entry into the target cell population and the formation of syncytia in cell culture. To define the role of the HIV type 2 fusion peptide during infection and syncytium formation, we introduced 8 amino acid substitutions into the hydrophobic amino terminus of gp41, changing either the hydrophobicity, the charge, or the polarity of the amino acid. Viruses containing the envelope mutations were analyzed for their syncytium-inducing capacities, levels of infectivity, and envelope processing and expression. Mutations that increased the hydrophobic nature of the fusion peptide increased syncytium formation, whereas mutations which increased the charge and the polarity and/or decreased the hydrophobicity of the fusion domain severely reduced the capacity of the virus to induce syncytia. However, viruses severely compromised for syncytium formation exhibit only slightly lower levels of infectivity.
引用
收藏
页码:4532 / 4535
页数:4
相关论文
共 22 条
[1]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[2]   IDENTIFICATION OF THE FUSION PEPTIDE OF PRIMATE IMMUNODEFICIENCY VIRUSES [J].
BOSCH, ML ;
EARL, PL ;
FARGNOLI, K ;
PICCIAFUOCO, S ;
GIOMBINI, F ;
WONGSTAAL, F ;
FRANCHINI, G .
SCIENCE, 1989, 244 (4905) :694-697
[3]   SYNTHESIS, OLIGOMERIZATION, AND BIOLOGICAL-ACTIVITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 ENVELOPE GLYCOPROTEIN EXPRESSED BY A RECOMBINANT VACCINIA VIRUS [J].
CHAKRABARTI, S ;
MIZUKAMI, T ;
FRANCHINI, G ;
MOSS, B .
VIROLOGY, 1990, 178 (01) :134-142
[4]   DEVELOPMENT OF A SENSITIVE QUANTITATIVE FOCAL ASSAY FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTIVITY [J].
CHESEBRO, B ;
WEHRLY, K .
JOURNAL OF VIROLOGY, 1988, 62 (10) :3779-3788
[5]   ISOLATION OF A NEW HUMAN RETROVIRUS FROM WEST-AFRICAN PATIENTS WITH AIDS [J].
CLAVEL, F ;
GUETARD, D ;
BRUNVEZINET, F ;
CHAMARET, S ;
REY, MA ;
SANTOSFERREIRA, MO ;
LAURENT, AG ;
DAUGUET, C ;
KATLAMA, C ;
ROUZIOUX, C ;
KLATZMANN, D ;
CHAMPALIMAUD, JL ;
MONTAGNIER, L .
SCIENCE, 1986, 233 (4761) :343-346
[6]   DEMONSTRATION OF 2 DISTINCT CYTOPATHIC EFFECTS WITH SYNCYTIUM FORMATION-DEFECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS [J].
DEDERA, D ;
RATNER, L .
JOURNAL OF VIROLOGY, 1991, 65 (11) :6129-6136
[7]   A SYNCYTIA ASSAY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-I (HIV-I) ENVELOPE PROTEIN AND ITS USE IN STUDYING HIV-I MUTATIONS [J].
FELSER, JM ;
KLIMKAIT, T ;
SILVER, J .
VIROLOGY, 1989, 170 (02) :566-570
[8]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A REPLICATION COMPETENT HUMAN IMMUNODEFICIENCY TYPE-2 (HIV-2) PROVIRAL CLONE [J].
FRANCHINI, G ;
FARGNOLI, KA ;
GIOMBINI, F ;
JAGODZINSKI, L ;
DEROSSI, A ;
BOSCH, M ;
BIBERFELD, G ;
FENYO, EM ;
ALBERT, J ;
GALLO, RC ;
WONGSTAAL, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) :2433-2437
[9]   CHARACTERIZATION OF THE FUSION DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP41 [J].
FREED, EO ;
MYERS, DJ ;
RISSER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4650-4654
[10]   DETECTION OF A FUSION PEPTIDE SEQUENCE IN THE TRANSMEMBRANE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS [J].
GALLAHER, WR .
CELL, 1987, 50 (03) :327-328